Fig. 4

Nephrotoxic medication stopped within 7 days per treating specialty between the before (6th of April 2021–5th of October 2021) and after period (6th of October 2021–5th of April 2022). This figure only represents those patients who were using nephrotoxic medication at the start of the AKI episode. Numbers in the boxes indicate for how many alerts, at least one nephrotoxic medication was stopped per patient that had a PCr follow up, as compared to the total alerts per treating specialty

Box 1: memo text as shown in our EHR system when the AKI alert identified the patient as having AKI

According to the KDIGO guidelines, this patient has acute kidney injury (AKI)

Follow up the kidney function

Be aware of the use of nephrotoxic medication and consider changing medication dosage. If necessary, please contact the pharmacist (phone number)

For questions about kidney function deterioration, consider consult with the internal medicine (phone number) or nephrology department (phone number)

For more info, please find the AKI-alert document in our iProva system

Box 2: memo text as shown in our EHR system when the patient did not have a baseline PCr measurement

Not able to evaluate according to the KDIGO guidelines due to no available PCr measurement in the previous 365 days